Monitoring SARS-CoV-2 Surrogate TGEV Individual Virions Structure Survival under Harsh Physicochemical Environments

Monitoring SARS-CoV-2 Surrogate TGEV Individual Virions Structure Survival under Harsh Physicochemical Environments

Effective airborne transmission of coronaviruses via liquid microdroplets requires a virion structure that must withstand harsh environmental conditions. Due to the demanding biosafety requirements for the study of human respiratory viruses, it is important to develop surrogate models to facilitate...

Full description

Bibliographic Details
Main Authors:	Miguel Cantero, Diego Carlero, Francisco Javier Chichón, Jaime Martín-Benito, Pedro José De Pablo
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Series:	Cells
Subjects:	physical virology coronavirus mechanical properties disinfection uncoating
Online Access:	https://www.mdpi.com/2073-4409/11/11/1759

Similar Items

Broad-Spectrum, Potent, and Durable Ceria Nanoparticles Inactivate RNA Virus Infectivity by Targeting Virion Surfaces and Disrupting Virus–Receptor Interactions
by: Candace R. Fox, et al.
Published: (2023-07-01)

The pH stability of foot-and-mouth disease virus
by: Hong Yuan, et al.
Published: (2017-11-01)

Transportin-3 Facilitates Uncoating of Influenza A Virus
by: Jiahui Zou, et al.
Published: (2022-04-01)

Toward the Specificity of Bare Nanomaterial Surfaces for Protein Corona Formation
by: Fabio Vianello, et al.
Published: (2021-07-01)

The Role of Capsid in HIV-1 Nuclear Entry
by: Anabel Guedán, et al.
Published: (2021-07-01)

Disinfection measures and control of SARS-COV-2 transmission
by: Phelipe Magalhães Duarte, et al.
Published: (2020-04-01)

Investigating the Effectiveness of Different Disinfectants in Removing the Coronavirus: A Review Study
by: Maryam Nouri Goushki, et al.
Published: (2022-06-01)

Disinfection of Surfaces Contaminated with SARS-CoV-2 Coronavirus by UV Radiation of Low-Pressure Mercury-Vapour Lamp
by: D. N. Masyakin, et al.
Published: (2023-07-01)

mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19
by: Christina M. Kackos, et al.
Published: (2023-02-01)

Comparison of DNA vaccines with AS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2
by: Praveen Neeli, et al.
Published: (2023-07-01)

Unique immune profiles in collaborative cross mice linked to survival and viral clearance upon infection
by: Jessica B. Graham, et al.
Published: (2024-03-01)

Extensive neutralization against SARS-CoV-2 variants elicited by Omicron-specific subunit vaccine as a heterologous booster
by: Pai Peng, et al.
Published: (2022-11-01)

Propagation, Inactivation, and Safety Testing of SARS-CoV-2
by: Alexander S. Jureka, et al.
Published: (2020-06-01)

The Ubiquitin-Proteasome System Facilitates Membrane Fusion and Uncoating during Coronavirus Entry
by: Xiao Yuan, et al.
Published: (2023-09-01)

A Sensitive Yellow Fever Virus Entry Reporter Identifies Valosin-Containing Protein (VCP/p97) as an Essential Host Factor for Flavivirus Uncoating
by: Shuo Zhang, et al.
Published: (2020-08-01)

Daxx Inhibits HIV-1 Reverse Transcription and Uncoating in a SUMO-Dependent Manner
by: Sarah Maillet, et al.
Published: (2020-06-01)

PF74 and Its Novel Derivatives Stabilize Hexameric Lattice of HIV-1 Mature-Like Particles
by: Alžběta Dostálková, et al.
Published: (2020-04-01)

How Viruses Use the VCP/p97 ATPase Molecular Machine
by: Poulami Das, et al.
Published: (2021-09-01)

Disassembling the Nature of Capsid: Biochemical, Genetic, and Imaging Approaches to Assess HIV-1 Capsid Functions
by: Zachary Ingram, et al.
Published: (2021-11-01)

A GAN-Augmented Corrosion Prediction Model for Uncoated Steel Plates
by: Feng Jiang, et al.
Published: (2022-05-01)

Association of ABO Blood Type with Infection and Severity of COVID-19 in Inpatient and Longitudinal Cohorts
by: Tiffany Eatz, et al.
Published: (2023-09-01)

CO² filtration during pneumoperitoneum inflation and deflation in patients undergoing laparoscopy during the COVID-19 pandemic
by: GUSTAVO MUNAYER ABRAS, et al.
Published: (2021-01-01)

Molecular evolution and targeted recombination of SARS-CoV-2 in South Korea
by: Atanas V. Demirev, et al.
Published: (2023-09-01)

The survival of murine hepatitis virus (a surrogate of SARS-CoV-2) on conventional packaging materials under cold chain conditions
by: Tiancheng Xie, et al.
Published: (2023-12-01)

Insights on the evolution of Coronavirinae in general, and SARS-CoV-2 in particular, through innovative biocomputational resources
by: Daniel Andrés Dos Santos, et al.
Published: (2022-07-01)

Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions
by: Yannic C. Bartsch, et al.
Published: (2023-05-01)

Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2
by: Elena Mitsi, et al.
Published: (2022-04-01)

How Influenza Virus Uses Host Cell Pathways during Uncoating
by: Etori Aguiar Moreira, et al.
Published: (2021-07-01)

HIV-1 Uncoating and Nuclear Import Precede the Completion of Reverse Transcription in Cell Lines and in Primary Macrophages
by: Ashwanth C. Francis, et al.
Published: (2020-10-01)

Overlap Intensity: An ImageJ Macro for Analyzing the HIV-1 In Situ Uncoating Assay
by: Zachary Ingram, et al.
Published: (2021-08-01)

THE ROLE OF THE NEONATAL FC RECEPTOR IN THE UNCOATING OF ECHOVIRUSES AND COXSACKIEVIRUS A9
by: P. S. Usoltseva, et al.
Published: (2019-06-01)

A scoping review on the impact of hydrophilic versus non-hydrophilic intermittent catheters on UTI, QoL, satisfaction, preference, and other outcomes in neurogenic and non-neurogenic patients suffering from urinary retention
by: Kim Bundvig Barken, et al.
Published: (2022-09-01)

Two-years antibody responses following SARS-CoV-2 infection in humans: A study protocol
by: Arguni, Eggi, et al.
Published: (2022)

Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape
by: Roberta Marzi, et al.
Published: (2023-01-01)

Mutating novel interaction sites in NRP1 reduces SARS-CoV-2 spike protein internalization
by: Debjani Pal, et al.
Published: (2023-04-01)

Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines
by: Puthupparampil V. Scaria, et al.
Published: (2022-08-01)

SARS-CoV-2 antigen-carrying extracellular vesicles activate T cell responses in a human immunogenicity model
by: Sarah E. Cummings, et al.
Published: (2024-01-01)

Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron
by: Jakob Kreye, et al.
Published: (2023-04-01)

HLA-DP diversity is associated with improved response to SARS-Cov-2 vaccine in hematopoietic stem cell transplant recipients
by: Juliette Villemonteix, et al.
Published: (2023-05-01)

Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination
by: Shinya Yamamoto, et al.
Published: (2023-07-01)